Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OXFD

Oxford Immunotec Global (OXFD) Stock Price, News & Analysis

Oxford Immunotec Global logo

About Oxford Immunotec Global Stock (NASDAQ:OXFD)

Advanced Chart

Key Stats

Today's Range
$21.99
$21.99
50-Day Range
$21.88
$21.99
52-Week Range
$8.37
$23.11
Volume
N/A
Average Volume
1.10 million shs
Market Capitalization
$570.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OXFD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Immunotec Global and its competitors with MarketBeat's FREE daily newsletter.

OXFD Stock News Headlines

A Game-Changing Vaccine
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Nigeria rolls out new Oxford R21 malaria vaccine
See More Headlines

OXFD Stock Analysis - Frequently Asked Questions

Oxford Immunotec Global PLC (NASDAQ:OXFD) released its quarterly earnings results on Tuesday, November, 3rd. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The company earned $19.44 million during the quarter, compared to analysts' expectations of $18.58 million. Oxford Immunotec Global had a negative net margin of 30.51% and a negative trailing twelve-month return on equity of 8.39%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Immunotec Global investors own include Intel (INTC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Dynavax Technologies (DVAX), Enterprise Products Partners (EPD) and Gold Resource (GORO).

Company Calendar

Last Earnings
11/03/2020
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:OXFD
CIK
1586049
Fax
N/A
Employees
273
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.81 million
Net Margins
-30.51%
Pretax Margin
N/A
Return on Equity
-8.39%
Return on Assets
-7.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.96
Quick Ratio
14.85

Sales & Book Value

Annual Sales
$73.71 million
Price / Sales
7.75
Cash Flow
$0.02 per share
Price / Cash Flow
1,408.78
Book Value
$8.08 per share
Price / Book
2.72

Miscellaneous

Outstanding Shares
25,962,000
Free Float
N/A
Market Cap
$570.90 million
Optionable
Not Optionable
Beta
1.42
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:OXFD) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners